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ABSTRACT 
Oocytes accumulate mRNAs in the form of maternal ribonucleoprotein (RNP) 
particles, the protein components of which determine the location and stability of 
individual mRNAs prior to translation. Scd6 proteins, typified by RAP55, functions in 
a wide range of eukaryotes in repressing translation and relocating mRNPs to 
processing bodies and stress granules. Here we describe in Xenopus laevis a variant of 
RAP55, xRAPB, a member of the LSM14B family of proteins found in many other 
organisms, which also contains conserved Lsm and FDF domains but differs in 
containing fewer RGG repeats. xRAPB differs from xRAPA in other respects: it is 
expressed at high concentration earlier in oogenesis; it interacts specifically with the 
RNA helicase Xp54; it is a component of mRNP particles with a different size 
distribution; its over-expression leads to selective binding to translatable mRNA 
species without evidence of translation repression or mRNA degration. Since Xp54 is 
a dominant repressor of translation, activation appears to be effected by the 
dislocation of Xp54 from xRAPB. 
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1. Introduction 
 
Throughout its existence, mRNA is associated with a wide range of proteins that 
determine its history and fate: co-transcriptional processing, nucleocytoplasmic 
transport, cellular localization and ability to be translated, result from a succession of 
interactions with protein factors and microRNAs (Muller-McNicoll and Neugebauer, 
2013). Although many RNA sequence- and structure-specific proteins have been 
identified, little is known of the extent of heterogeneity in protein composition across 
the range of mRNP particles.  In developing organisms, substantial amounts of mRNP 
are formed and stored until required for the synthesis of stage-specific proteins, 
whereas other mRNPs undergo immediate translation to establish the metabolic 
machinery (Lai and King, 2013).  Not only the timing of translation initiation is 
determined but also the cessation of translation and mRNA decay.  These and more 
subtle effects on the regulation of translation are incurred through the remodelling of 
mRNP particles. Key processes include: addition and removal of translation masking 
proteins, cytoplasmic regulation of poly(A) tail length, binding of translation 
initiation factors to the 5' cap structure, interaction of proteins bridging the 3' and 5' 
ends of the mRNA, mRNA localization, decapping and hydrolysis of the mRNA 
(Balagopal and Parker, 2009). 
    A paradigm for these various effects has been established from studies on 
oogenesis and early development of Xenopus laevis. Over a period of months, oocytes 
accumulate large numbers of non-translating, maternal mRNA molecules (>10
11
/ 
oocyte) that are stored to be mobilized to polysomes during later stages of oogenesis, 
oocyte maturation and, after fertilization, early embryogenesis. During their storage 
phase, most of these mRNAs have relatively short poly(A) tails (10-30 residues) at 
their 3' termini (Cabada et al., 1977). Several abundant proteins are found to be 
associated with these maternal mRNAs to form large RNA-protein complexes which 
mostly sediment at 30-80 S and have a buoyant density in CsCl of 1.36 g.cm
-3
 
(equivalent to a protein:RNA mass ratio of 4:1).  
    The four most abundant proteins have apparent (electrophoresis) molecular masses 
between 50-60 kDa (Darnbrough and Ford, 1981): the two slowest migrating were 
identified as cold-shock domain Y-box proteins, FRGY2a/b (YB2: Deschamps et al., 
1992; Murray et al.,1992) and the next as the DEAD-box RNA helicase Xp54/Dhh1 
(Ladomery et al., 1997). The fourth protein, of 52 kDa, described in this report as 
xRAPB, is identified as a variant of RAP55 which is expressed in a wide range of 
organisms (Marnef et al., 2009). RAP55 was first identified as an RNA-associated 
protein expressed in oocytes of the amphibian Pleurodeles waltl (Lieb et al. 1998). Its 
orthologue is also expressed in Xenopus oocytes and is here referred to as xRAPA. All 
of the RAP55 proteins, including xRAPA and xRAPB, belong to the Scd6 family 
(Anantharaman and Aravind, 2004), characterized by a multidomain organization 
consisting of a conserved N-terminal Lsm domain and varied central and C-terminal 
regions defined by an FDF domain and RGG repeats (Albrecht and Lengauer, 2004). 
In this report we examine to what extent structural differences between xRAPA and 
xRAPB are reflected in differences in function.   
    RAP55/xRAPA has been shown to act as a translation repressor (Tanaka et al., 
2006), as have the core mRNP proteins, YB2a/b (Kick et al.,1987: Matsumoto et al., 
1996; Yurkova and Murray, 1997; Sommerville, 1999) and Xp54 (Minshall and 
Standart, 2004: Minshall et al., 2009), along with other mRNP proteins: CPEB 
(Minshall et al., 2007), 4-ET (Minshall et al., 2007) and P100/Pat1 (Marnef et al., 
2010: Nakamura et al., 2010).  However, other proteins, involved in mRNP 
trafficking and translation activation during oogenesis, have yet to be identified. Here 
we describe several features of xRAPB, which distinguish it from RAP55/xRAPA, 
specifically in having a key role in the regulation of mRNA metabolism during the 
early stages of oocyte development. 
 
 
2. Materials and methods  
2.1 Sequencing and cloning 
    Sequence information for Xenopus laevis xRAPA was obtained originally from 
EST clones BG408666 and BG486665 (European Bioinformatics Institute: 
www.ebi.ac.uk) which showed 74% protein identity with RAP55 of Pleurodeles 
waltii (UNIPROT Q9YH12; www.uniprot.org ; Lieb et al., 1998) and were known to 
be expressed in oocytes of X. laevis. A complete coding sequence was constructed 
from PCR reactions and later found to be identical at the protein level to that of 
IMAGE clone 3405473 (I.M.A.G.E Consortium: www.imageconsortium.org). 
xRAPB was initially detected by peptide sequencing of an mRNP protein of 52 kDa 
isolated from stage I oocytes of X. laevis: one of the peptide sequences, M/VEQAV, 
did not occur in either RAP55 or xRAPA, but was later detected in a human clone 
(UNIPROT Q9BX40) which showed 45% identity with RAP55. X. laevis EST clones 
BI444610 and BG731378 were used to generate more extensive and overlapping 
sequences which were found to form a complete 5’ insert in IMAGE clone 3473035 
and a complete 3’ insert in IMAGE clone 4674033, with a 299 bp overlap between 
them. 
 
2.2 Expression vectors 
    PCR copies from cDNA clones encoding complete sequences of xRAPA and 
xRAPB were inserted into the pCS2*mt-SGP vector between the unique Eco RI site 
immediately downstream of the 6-times myc epitope  and the Xba I site immediately 
upstream of the in-frame GFP sequence as described previously (Smillie and 
Sommerville, 2002). Stop codons were retained, or inserted, in a second set of vectors 
to generate transcripts lacking part or all of the GFP sequence. The pCGT vector 
expressing the complete sequences of Xp54 following a leader sequence encoding a 
T-epitope has been described (Smillie and Sommerville, 2002). All in vivo expression 
was driven from the CMV promoter. For in vitro expression, proteins were generated 
using the TNT Quick Coupled Transcription/Translation System (Promega, Madison, 
WI) according to the supplier’s instructions. Briefly, 0.5-2 g of plasmid DNA was 
used in combination with 20 Ci of [35S]-methionine (Redivue >1000 Ci/mmole; 
Amersham Biotech. GE Healthcare) and either T7 or SP6 RNA polymerase 
(Promega). After incubation at 30
o
C for 90 min., the reactions were filtered through 
Sephadex G-50 (GE Healthcare) by centifugation in micro-pipette tips to separate the 
products from unincorporated radioactivity and small molecules. The integrity of 
radiolabelled products was checked by SDS-PAGE/autoradiography. Quantitation of 
incorporation was calculated by sampling aliquots in duplicate on to GF/A glass fibre 
filters (Whatman, GE Healthcare), with and without TCA precipitation and followed 
by scintillation counting according to supplier’s instructions (Promega). 
 
2.3 Morpholinos 
    Antisense morpholinos (Gene Tools, Philomath, OR) were directed against RNA 
sequences adjacent to translation start site (bold, where included): 
Xp54 mRNA     3’TACTCGTGGCGGTCTTGTCTCTTGG  5’ 
YB2 mRNA   3’CCTCGTACTCACTCCGCCTTCGGGC  5’ 
xRAPB mRNA  3’GGTATCAGGTTTCTGCTCGTAGTAC  5’ 
xRAPA mRNA  3’GTAGGTAGGCCCTCTATCCTACTCG  5’ 
pCS transcripts  3’GTTCGATGAACAAGAAAAACGACCT  5’ 
pCTG transcripts  3’TACCGAAGATCCTACCGTAGCTACT  5’ 
  
Control      3’CCTCTTACCTCAGTTACAATTTATA  5’ 
All injected antisense morpholinos showed specific down-regulation of both 
endogenous and recombinant forms of the target proteins. No deleterious effect on 
oocytes were observed. 
 
2.4 Oocyte isolation and extraction 
    Ovary was excised from immature X. laevis and oocytes were released and 
maintained in OR-2 medium and sorted into individual stages as described in detail 
(Sommerville, 2010). Pools of ~1000, 400, 100 and 40 oocytes, of stages I, II, III and 
IV were homogenized in HB: 0.1 M NaCl; 2 mM MgCl2; 2 mM dithiothreitol, 20mM 
Tris-HCl, pH 7.5. Yolk and lipid were extracted with 1,1,2-trichlorotrifluoroethane 
(Evans and Kay, 1991). After centrifugation at 10,000 rpm for 15 min at 0
o
C in a 
Sorvall SS-34 rotor, the clarified supernatant (SN10) was carefully removed. The 
extracts were maintained at <2
o
(Promega) and where appropriate 5 mM EDTA (Sigma). Poly(A
+
) RNP was bound to 
and eluted from oligo(dT) cellulose (Type 7; Pharmacia, GE Healthcare) as described 
previously (Ladomery et al., 1997). Typical recovery of poly(A
+
) RNP from early 
stage oocytes was 250-350 g/ml eluate. 
 
2.4 Primary antibodies 
    Poly(A)
+
RNP from early (stage I) oocytes was separated into a heat stable 
supernatant containing YB2a/b (Deschamps et al., 1992) and a heat-labile precipitate 
containing principally Xp54 and xRAPB. Antibodies were raised against the renatured 
proteins from these two fractions. Rabbits producing anti-YB2 generally gave equal 
reactivity to the a and b forms. Rabbits producing antibodies to the heat-labile 
proteins gave variable immuno-reactivities, either against Xp54 or xRAPB. 
Antibodies specific for Xp54 and p52 (xRAPB) were raised against gel-isolated 
proteins which were renatured by staged dilution from 8M urea into HB (Ladomery et 
al., 1997; Sommerville and Ladomery, 1996). Rabbit anti-ERK2 was obtained from 
Santa Cruz Biotech. (Santa Cruz, CA) rabbit anti-phospho-MAP kinase from Cell 
Signalling (Danvers, MA). Rabbit anti-CPEB was kindly supplied by Laura Hake. 
Mouse monoclonal antibodies to the c-myc epitope (clone 9E10, Sigma-Aldrich, St 
Louis, MO) and the bacteriophage T7 epitope (Novagen, Merck, Darmstadt) were 
used as recommended. 
 
2.6 Oocyte injection and radiolabelling  
    Stage IV oocytes from albino females were randomly distributed into four sets of 
40-50 oocytes and each set was colour-coded using vital stains as described 
(Sommerville, 2010). The different sets were used for injection of different expression 
vectors or morpholinos or as controls. For over-expression studies, 10 nl aliquots 
containing ~10 pg of purified plasmid DNA were injected into the visible nucleus of 
colour-coded albino oocytes. Alternatively,  RNA transcribed with T3 or T7 
polymerase (MessageMachine, Ambion, Waltham, MA) from linearized vectors (10 
the same method but labeled with 
32
[P]-CTP (0.1 mCi/ml at >1000 Ci/mmole; 
Amersham). For knock-down expression, antisense or control morpholinos (5 ng in 
20 nl aliquots) were injected into the cytoplasm. After injection the oocytes were 
pooled and incubated together in OR-2 at room temperature (20-22 
o
C) for periods of 
6 to 36 h. For metabolic labelling of proteins, sets of 25 colour-coded oocytes from 
each injection treatment were pooled and labelled by addition of 30 l of 
[
35
S]methionine (0.1 mCi/ml at >1000 Ci/mmole; Amersham) to a total volume of 3 
ml of OR2 in 30 mm diameter plastic dishes. At each time point, 5 oocytes of each 
colour were removed with a minimum of liquid and rinsed twice in 2 ml of OR2 
before transfer to a 0.5 ml centrifuge tube and frozen on dry ice. Quantitation of 
[
35
S]methionine incorporation/protein synthesis was carried out as described (Keiper 
and Rhodes, 1997).  
 
 
2.7 Immunoblotting 
    Proteins, equivalent to one oocyte, were separated by SDS-PAGE, transferred to 
nitrocellulose (0.45 micron, Pierce Biotech. Thermo Fisher) and immunoblotted as 
described previously (Ryan et al., 1999). Primary antisera or IgG were used at 1:5,000 
or 1:10,000, secondary antibodies were goat-anti-rabbit or goat-anti-mouse IgG 
conjugated to IR Dye 800CW (Li-COR, Odyssey Biosciences, Lincoln, NE) and were 
all used at 1:40,000. Fluorescent bands were recorded using an Odyssey (Li-COR, 
Clx) infrared imaging system. All immunoblots shown are representative of those 
obtained from at least two experiments.  
 
2.8 Immunostaining 
    Xenopus laevis ovary was fixed in 2% trichloroacetic acid, dehydrated, embedded 
in wax and sectioned on to glass slides. Dewaxed sections were rinsed with PBST, 
incubated for 1 hour at 20oC with anti-p54 diluted 1:200 in 10% FCS/PBST, rinsed 
five times in PBST for 10 min, then incubated with FITC-conjugated anti-rabbit IgG 
(Chemicon) diluted 1:200 in 10% FCS/PBST. After rinsing in PBST a further five 
times, the sections were mounted in 20% glycerol / PBST and viewed using an 
Olympus BX51 fluorescence microscope fitted with an SIS View Firewire CC-12 
digital camera (Olympus Soft Imaging, 48149 Munster, Germany).  
 
2.9 Immunoprecipitation 
    Antibodies were linked to ProSep-vA beads (Millipore, Watford, UK) and proteins 
or mRNP bound from HB containing 0.05% NP-40 (Sigma) and released as described 
previously (Ryan et al., 1999).  
 
2.10 UV crosslinking 
   Samples of poly(A)
+
RNP (25-35 g in 100 l HB) were placed in a silicone-treated 
glass depression tray seated on ice and irradiated with 254-nm light at 6,000 W/cm2 
for 5 min to establish protein-RNA crosslinks or 30 min to produce (more extensive) 
protein-protein crosslinks. Half of irradiated samples were treated with 1 mg/ml 
ribonuclease A at 37
o
C for 30 min to resolve close protein-protein association. 
 
2.11 Rate sedimentation analysis 
    Clarified oocyte extracts and poly(A
+
) fractions were layered on 10-25% glycerol 
gradients made up in: 0.1 M NaCl; 2 mM MgCl2; 2 mM dithiothreitol; 20 mM Tris-
HCl, pH 7.5 plus 0.05% NP-40, g/ml 
cycloheximide. For ribosome dissociation, MgCl2 was  replaced with 5 mM EDTA. 
After centrifugation at 36,000 rpm in a 6 x 5 ml swing-out rotor (Beckman SW50Ti) 
at 0
o
C for 2-3 hours, the tube contents were fractionated. Fractions were analysed for 
proteins by immunoblotting. Sedimentation rates were calculated using 80S 
ribosomes and 60S and 40S ribosomal subunits run in parallel gradients and scanned 
through a flow cell measuring absorbance at 254 nm. 
 
2.12 Density gradient centrifugation 
   Unfixed poly(A)
+
RNP samples (50-100 l) were layered on preformed gradients of 
6-48% Cs2SO4 in 0.1% NP40 (Sigma) and 50 mM sodium phosphate, pH 7.0. After 
centrifugation at 35,000 rpm for 16 h at 18
o
C in a Beckman SW50Ti rotor, the tube 
contents were fractionated. Density values were obtained by refractometry. Each 
fraction was diluted with 3 vol. dH2O, then RNP and proteins were ethanol 
precipitated, for protein extraction with addition of 10 g of cytochrome C and for 
RNA extraction with 10 g of yeast tRNA as carriers. Proteins were recovered from 
precipitatated fractions by standard preparation procedure for SDS-PAGE. RNA was 
recovered by SDS-protease treatment and standard phenol extraction. Unfixed 
poly(A)
+
RNP was also separated on preformed CsCl gradients, formed and analysed 
as above. 
     
2.13 RNA extraction, hybridization and RT-PCR 
    RNA was isolated extracts of 25 oocytes or acetone- or ethanol-precipitated 
gradient fractions or from immunoprecipitates raised in 250 g HB plus 
RNasin and from their supernatants, by addition of SDS to 1% followed by 
extractions with equal volumes of phenol-chloroform-isoamyl alcohol then chloform-
isoamyl alcohol. 1/10
th
 volume of 5M sodium acetate and 20 g transfer RNA 
(Sigma) were added to the extracts and RNA was ethanol precipitated. Dried pellets 
were raised in RNase-free H2O. RNA for hybridization analysis was either separated 
by gel electophoresis and transferred to nylon membranes or applied directly to the 
membranes using a Hybri-Slot Manifold (BRL, Bethesda) and hybridized with 
32
[P]-
CTP labelled antisense probes essentially as described (Sheets et al., 2010). RNA as a 
template for two-stage RT-PCR was used with random hexamers in the ImProm-II
TM
 
Reverse Transcription System (Promega) to generate cDNA followed by 
amplification with GoTaq
TM
 Master Mix (Promega) as specified by the manufacturer. 
Gene-specific primer pairs were used to generate products of 300-400 bp after 28 
cycles. Products were analysed by electrophoresis on agarose gels as described 
(Huber and Zhao, 2010). 
Gene specific primer pairs: 
Nuclear actin (F): 5’CTCACCCTGAAGTATCCCATTG; (R): 
5’GAAGCAGCTGTTGCCATTT  
tubulin (F): 5’CCCAACAACGTTAAGACCG; (R): 5’CCTCCTCTTCCCCTTCCT 
Cyclin B1 (F): 5”CTTTGGCTGGAAAGAGGGTTG; (R): 
5’CTGACTGCTTGTGCATCCTCA 
D7 (F): 5’CCCTAAACAGGAGCTTGATCTG; (R): 5’CTGCACCATGGGTTTGTATTTG 
EF1 (F): 5’GGAGAATTTGAGGCTGGTATCT; (R) 
5’GAGTCGTAGAGGCTTGTTAGTG 
HDAC (F): 5”CGGTTACGGGATGGGATTGAC; (R): 
5’GTTGGATGGGCTGATGTGGAAG 
H1M (F): 5’CTGAGGGAGGCAACAAGGAAAAT; (R): 
5’CTGCTCTGCATTTGGGTCTAC  
Mos (F): 5’GTGGCGCTGAAGAAGGTAAA; (R): 5’ATAGGCCACTACCGCATAGA 
Nanos1 (F): 5’CTGCAGCCTCAGAGAGAAGG; (R): 5’CCACACAAAGGGCAAGTGTA 
rp-L14 (F): 5’GTCGTACCAACTCCAGTTTCA; (R): 5’GTAGACTTCACGGGCCTTAC 
Vg1 (F): 5’CCATACCCGCTGACAGAAATA; (R): 5’CAGCTAACAGTCAAGGCAAATC 
Xcat2 (F): 5’GCTTTGACTCATGGAGCGAC; (R): 5’GCCGAGTGAGACATCAGTGT 
YB1 (F): 5’CAGTGTGGGAGATGGTGAAC; (R): 5’GAACTGGAGCATTGGAGTATTG
  
 
3. Results 
3.1 Identification and expression of xRAPB 
    The original guinea pig antibody raised against recombinant RAP55 recognized 
three proteins in oocyte extracts from Pleurodeles waltl with apparent masses of 140, 
68 and 56 kDa, but only one protein from Xenopus laevis with a mass of 52 kDa (Lieb 
et al., 1998).  The 68 kDa protein was named RNA-associated protein 55 (the 
predicted mass of the sequenced clone being 55 kDa). The rabbit antibody raised 
against a 52 kDa protein isolated from Xenopus mRNP (Sommerville and Ladomery 
1996) recognizes only the 52 kDa protein from Xenopus and the 56 kDa protein from 
Pleurodeles (Fig. 1A). Subsequent cDNA cloning, based on peptide analysis of the 52 
kDa protein, eventually identified it as a shorter variant of RAP55, one which we 
named RapB/xRAPB (Weston and Sommerville, 2006; Marnef et al., 2009). The 
relationships between these proteins, including a form identical to xRAPB but with a 
single internal deletion (xRAP42; Arthur et al., 2009), are indicated (Fig. 1B).  
    Immunoblotting of extracts from developing oocytes using anti-p52/anti-xRAPB 
shows highest reactivity with early stages (I-II), with decreasing signal as oogenesis 
proceeds (Fig. 1C, top panel). Quantitation of the encoding mRNA/oocyte mass by 
RT-PCR reveals a similar pattern (Fig. 1C, bottom panel). However, on a per oocyte 
basis, the amount of xRAPB-encoding mRNA increases through oogenesis, indicating 
that expression of xRAPB, itself, is subject to translational control.  
    Immunostaining of ovary sections with anti-xRAPB reflects the immunoblotting 
results, with reaction steadily decreasing from early stage to be low in concentration 
by late stage (Fig. 1D). It is also apparent that the cognate protein is almost 
exclusively cytoplasmic, as has been shown for RAP55/xRAPA (Tanaka et al., 2006).  
    Immunoblotting of oocyte fractions bound or unbound by oligo(dT)-cellulose 
shows that the protein detected by anti-xRAPB is bound to an extent similar to bona 
fide mRNP components, such as Xp54, YB2 and CPEB (Fig. 1E). Binding efficiency 
is similar in the presence of either Mg
2+ 
or EDTA, conditions which may influence 
intermolecular associations.  Xp54, YB2 and xRAPB continue to be present in the 
poly(A)
+
 fractions after progesterone-induced maturation, but at lower levels. 
Immunoreaction with anti-ERK2 is shown as a non-mRNP control and with anti-
pMAPK as an oocyte maturation marker. 
    All indications are that xRAPB is an integral component of mRNP particles, 
particularly of a major population present in early oocytes. That xRAPB is a stably-
bound component of these particles can be shown by equilibrium gradient 
centrifugation of unfixed poly(A)
+
 RNP through high salt (15-40% Cs2SO4). 
Immunoblotting of gradient fractions with a mixture of antibodies to recognize the 
major mRNP proteins shows that xRAPB together with Xp54 remain bound to RNA 
(at a buoyant density of 1.44 g.cm
3
) after much of the YB2 has been stripped off and 
recovered at around 1.22 g.cm
3
 (Fig.1F). That the density peak represents the core of 
mRNP particles is demonstrated by extraction of RNA from the gradient fractions and 
hybridization with labelled probes directed against a range of early-expressed 
mRNAs, panels of two of which, nucleolin and histone deacetylase (HDACm) are 
shown (Fig. 1F). Thus the vast majority of hybridization signal corresponds to the 
position of the xRAPB immunostaining signal. For comparison, particles containing 
all of the major mRNP proteins can be obtained within a single density peak at around 
1.39 g.cm
3
 on banding in CsCl gradients (Fig. 1F). This density in CsCl corresponds 
to a protein:RNA ratio approaching the value of 4:1 which is normally quoted for 
intact mRNP (Cummings and Sommerville, 1988). The differential removal of YB2, 
especially of YB2b, from mRNP in moderate salt conditions (1 M NaCl) has already 
been noted (Ladomery and Sommerville, 1996) and may help explain better retention 
of YB2 in CsCl than in Cs2SO4. 
 
3.2 Comparison of interactions of xRAPA and xRAPB with Xp54  
    Previous results have indicated a direct interaction of xRAPB with Xp54 helicase, 
an interaction that is not evidenced in early-stage oocytes with xRAPA (Minshall et 
al. 2007). Here we extend these observations by examining protein-protein 
interactions that occur using in vitro synthesised xRAPA, xRAPB and Xp54 (Fig. 2A) 
and compare the results with those obtained through crosslinking of proteins within 
native RNP particles. 
    Interaction of xRAPB with Xp54 can be shown by reciprocal immunoprecipitation 
from combinations of the in vitro-synthesized proteins. Incubation of xRAPB with 
Xp54 and xRAPA with Xp54 was followed by binding and elution from immobilized 
anti-Xp54 and anti-xRAPB. Autoradiographs show that anti-Xp54 co-precipitates 
xRAPB much more effectively than xRAPA (Fig. 2B, top) and that anti-xRAPB co-
precipitates Xp54 with xRAPB but much less with xRAPA (Fig. 2B, bottom).  
    That xRAPB and p54 make close contacts in vivo can be shown by u.v.-
crosslinking of native mRNP particles (Fig. 2C). Here, both xRAPB and Xp54 are 
found in complexes with identical mobilities on SDS-PAGE at about 110 kDa, even 
on using heat-treated pellets which lack YB2 and mRNA and are reacted 
simultaneously with anti-xRAPB and anti-Xp54. This Mr value corresponds well with 
the interpretation of the formation of heterodimers. These complexes are not affected 
by ribonuclease treatment after irradiation. In comparison, other mRNP components 
(eg.YB2a/b) form differently-migrating complexes (right panel). Larger complexes 
running at the top of the gel and detected with anti-Xp54 and anti-YB2, but not with 
anti-xRAPB, are disaggregated on ribonuclease treatment. This observation suggests 
that xRAPB, unlike Xp54  and YB2, may have no direct RNA-binding activity.  
    These results indicate that, during early oogenesis, xRAPB is a natural partner 
protein for the RNA helicase Xp54, perhaps in selecting mRNAs for early translation. 
 
3.3 xRAPB expression complements Xp54 expression in the formation of mRP 
particles 
    Once assembled and processed in the nucleus, YB2- and Xp54-bound transcripts 
become restricted to the cytoplasm (Smillie and Sommerville, 2002), possibly through 
anchoring by Scd6 proteins. In order to study the interaction of xRAPB and Xp54 in 
the presumed cytoplasmic addition of xRAPB to mRNP particles, recombinant forms 
of the proteins were expressed in vivo after injection into mid-stage, oocytes. T7-
tagged Xp54 and myc-epitope-tagged xRAPB, or myc-epitope-tagged xRAPA, were 
co-expressed from CMV-driven vectors injected directly into oocyte nuclei. This 
approach has the advantage of accessing the complete, natural pathway of gene 
expression and therefore is more likely to produce correctly located and functioning 
proteins (Braddock et al., 1994; Matsumoto et al., 1998). The compositions of the 
three recombinant proteins, showing the location of their functional domains, are 
represented in Fig. 3A.  
    The relative rates of synthesis of the epitope-tagged proteins were compared with 
the levels of endogenous proteins by immunoblotting with anti-Xp54 and anti-
xRAPB. It was found that equivalence for both was reached at between 24 h and 48 h 
post-injection of the relevant vector (Fig. 3B). Interestingly, for both proteins, as the 
level of tagged protein increased, the level of endogenous protein appeared to show a 
corresponding decline, indicating possible homeostatic regulation. 
    The shorter-term kinetics of co-expression of the recombinant proteins were 
examined by injecting run-off transcripts (using T3 or T7 polymerase) into the 
cytoplasms of mid-stage oocytes and sampling for immunoblotting at two-hourly 
intervals. As can be seen (Fig. 3C), myc-tagged-xRAPB is detected and accumulated 
from 4 h post-injection.  However, co-expression with T7-tagged-Xp54 leads to 
earlier detection of both Xp54 and xRAPB (from 2 h). This co-operative effect was 
then exploited by examining mRNP assembly after nuclear co-injection.  
    As with co-precipitation of xRAPB and Xp54 from proteins synthesized in vitro 
(Fig. 2 B), immunoprecipitation from lysates of oocytes co-expressing myc-tagged 
xRAPB and T7-tagged Xp54 in vivo, showed co-precipitation using anti-myc epitope, 
anti-T7 epitope, anti-Xp54 or anti-xRAPB (Fig. 3D). Non-immune rabbit serum was 
used as a negative control. The extent of co-precipitation using anti-epitope tags to 
detect de novo-synthesized myc-xRAPB and T7-Xp54 corresponded well with co-
precipitation results using antibodies directed against the native proteins.  However, 
antibodies recognizing Xp54 were more efficient in co-precipitating xRAPB than 
were the antibodies recognizing xRAPB in co-precipitating Xp54. This would be 
expected if Xp54 bound to xRAPB constitutes only a sub-fraction of the Xp54 
population, assuming that the ectopically expressed proteins behave in a manner 
similar to their endogenous equivalents. 
    Stored mRNP particles typically sediment at 30-80S in rate-zonal gradients 
(Darnbrough and Ford, 1981).  In order to check whether xRAPB is actively 
incorporated in vivo into newly-synthesized  particles, epitope-tagged xRAPB and 
Xp54 were co-expressed in oocytes and their distribution was analysed after 
sedimentation in glycerol gradients. Assembly of newly synthesized xRAPB into 
mRNP particles was found to correspond (in size distribution) to that of newly 
synthesized Xp54 (Fig. 3E).  Pre-treatment of the oocyte extract with ribonuclease 
resulted in both xRAPB and Xp54 being resolved in smaller molecular complexes. In 
contrast, xRAPA, co-expressed with Xp54, appeared to prevent Xp54 from entering 
into larger mRNP particles, again pointing to the co-operation of xRAPB and Xp54, 
but a dislocation of xRAPA and Xp54, in early mRNP assembly (Fig. 3F). It should 
be noted that immunostaining of all three components can be detected in pelleted 
post-80S material.  
 
3.4 Comparison of the effects of knock-down and over-expression of xRAPA and 
xRAPB 
    Previous studies have shown that Xenopus xRAPA (RAP55) represses translation 
in an in vitro system and also in vivo in oocytes when tethered to a reporter RNA 
(Tanaka et al., 2006) as has Xp54 (Minshall et al. 2001, 2004). However, injection of 
anti-xRAPB IgG into oocytes does not interfere with the formation of masked mRNP 
particles, whereas injection of anti-Xp54 IgG releases masked reporter transcripts for 
translation (Braddock et al. 1994), indicating that xRAPB may not be a translation 
repressor. In order to explore this possibility, we compared the effects of knockdown 
and over-expression of xRAPB, xRAPA and Xp54. It has been generally assumed that 
stored mRNP particles are stable and accumulate until their protein products are 
required at the appropriate stage of development (reviewed, Weston and Sommerville, 
2006). However, the formation and stability of maternal mRNP appears to involve a 
much more dynamic scenario. As expected, injection of anti-sense morpholinos 
(a/sMOs) into the cytoplasm of oocytes expressing recombinant xRAPB and Xp54 
from nuclear vectors greatly inhibits their synthesis (Fig. 4A), but injection of a/sMOs 
directed against the endogenous mRNAs encoding these protein also results in 
significant inhibition (Fig. 4B).  No significant MO cross-reactions were detected in 
comparing all of the targeted proteins. These findings open the possibility of using 
a/sMOs to examine the effects of depletion of xRAPB, xRAPA and Xp54 on 
translation rates in injected oocytes. As can be seen (Fig. 4C), Xp54 a/sMO 
significantly increases the rate of protein synthesis, whereas xRAPB a/sMO gives 
slight repression. The effect of xRAPA a/sMO differs little from the effect of a non-
specific control MO. On comparing the spectrum of labelled proteins by SDS-PAGE / 
autoradiography (Fig.  4D, right panel) it can be seen that the a/sMO treatments result 
in differences of general signal intensity: there is no evidence for an increase or 
decrease in the translation of specific proteins. Also, comparison of the radiolabelling 
with protein staining in individual tracks indicates that the labelled bands do not fully 
correspond, either in intensity or migration. This reflects oocyte stage-specific 
translation and differental protein stability. Quantitation of track densities are shown 
in the accopanying table, again indicating that the most significant deviation from the 
control is the positive effect of anti-sense of Xp54 mRNA. 
    Results from the reverse experiment, examining the effect of increased expression 
of xRAPB, xRAPA and Xp54 on protein synthesis, are shown (Fig. 4E). Here there is 
a reversal of outcomes, with over-expression of Xp54 resulting in inhibition of protein 
synthesis and over-expression of xRAPB in an apparent activation. xRAPA gave no 
significant difference from the (mock-injected) control. The profiles of newly-
synthesized proteins (Fig. 4F) again showed differences in overall intensity. In the 
autoradiograph shown, the last two track represents synthesis after co-expression of 
myc-xRAPB and T7-Xp54, which can be compared with the expression of these 
proteins individually. In these tracks the over-expressed myc-xRAPB can be 
discerned at its slower migrating position (white dot and upper arrow), whereas over-
expressed T7-Xp54 is obscured in the heavier labelled region of the gel (white dot 
and lower arrow).  Quantitation of track densities confirm a significant inhibition of 
translation by over-expressed Xp54 and a modest increase in translation of xRAPB 
(this is with the myc-xRAPB band contribution subtracted from the total). Co-
expression with xRAPB with Xp54 leads to moderation of the repressor activity of 
Xp54 (Fig. 4F). The least we can conclude is that over-expresion of xRAPB does not 
inhibit the activity of already translating mRNAs. 
 3.5  xRAPB is associated with translating mRNAs 
        It might be expected that manipulated changes in translation rate would be 
reflected in changes in the distribution of mRNP particles, specifically in association 
with ribosomal components. Rate sedimentation analysis of extracts from mid-stage 
oocytes containing over-expressed Scd6 proteins show that the distribution of xRAPA 
remains typical of mRNPs containing endogenous Xp54 and YB2 (Fig. 5A, broken 
box area), whereas a significant proportion of the myc-xRAPB signal has moved into 
post-80S fractions not so well represented by Xp54 and YB2 (Fig. 5A, solid box 
area). The myc-xRAPB signal in faster sedimenting complexes is significantly 
weaker. The post-80S complexes are disassembled in the presence of EDTA (Fig. 
5B).  
    Whereas mRNP particles from early- to mid-stage oocytes have been described as 
forming a heterogeneous size distribution on rate-sedimentation gradients 
(Darnbrough and Ford, 1981; Cummings and Sommerville, 1988), native xRAPB is 
seen to be present in particles with a bimodal distribution, sedimenting in sub-80S and 
post-120S fractions. This contrasts with Xp54 and YB2, both of which form a 
continuous distribution across the 80S region (Fig. 5C, broken box area) and indicates 
that mRNP particles free of xRAPB are present in mid-stage oocytes. On the other 
hand, the distribution of xRAPB seen here is typical of that of separated stored mRNP 
and polysomes. Hybridization of gene-specific antisense probes with RNA extracted 
from the gradient fractions confirms that mRNA not translated during early oogenesis 
(eg. encoding cyclin B1, Fig. 5C) is not present in putative polysome fractions but, 
instead, remains in fractions associated with stored mRNA. On the other hand, early-
translated mRNA (eg. encoding -tubulin, Fig. 5C) extends into the polysome region, 
reflecting the bimodal distribution of xRAPB. Support for these distributions 
representing a distinction between mRNP storage and translation complexes can be 
seen from gradients of the same extracts pre-treated with EDTA, which result in the 
total disruption of post-80S RNP with cyclinB1 mRNA now sedimenting with Xp54 
and YB2 at less than 60S and the -tubulin mRNA sedimenting at less than 40S with 
xRAPB (Fig.5D). The bimodal distribution of xRAPB is better defined in early-stage 
oocytes (Fig. 5E), whereas all post-80S signal is absent from ectopically-expressed 
xRAPB in late-stage and matured oocytes (Fig. 5F). 
  
3.6 Identification of mRNA classes found in association with xRAPB 
    Confirmation of direct interaction of early-expressed mRNA species with xRAPB 
is obtained from RT-PCR of RNA extracted from immunoprecipitated RNP particles 
(Fig. 6). In order to standardize precipitation and to minimize potential 
immunological cross-reaction, both myc-tagged xRAPB and myc-tagged xRAPA 
were used as the targets for monoclonal anti-myc (cf. Huber and Zhao, 2010). As can 
be seen  (Fig. 6),  immunoprecipitates (P) from oocytes expressing myc-xRAPB 
contained mRNA species that are being translated in oocytes (for nuclear actin, -
tubulin, EF1a, ribosomal protein L14 and HDACm) but not stored mRNAs that are 
translated later at oocyte maturation (for cyclin B1 and c-mos), in the egg (for D7) 
and during early embryogenesis (for somatic YB1 and linker histone H1M). Actively 
translating mRNAs are not precipitated from oocytes expressing myc-xRAPA, 
whereas stored mRNAs are precipitated to varying extent. However, this analysis is 
complicated by instability of some stored mRNAs (eg. encoding cyclin B1 and c-
mos), but not of translating mRNAs or embryo-expressed mRNAs (eg. for H1M), in 
myc-xRAPA-expressing oocytes. Additionally, mRNAs that pass through localization 
pathways in early- to mid-stage oocytes (encoding Xcat2 and Vg1) but are 
translationally repressed during oogenesis were also immunoprecipitated along with 
xRAPB. 
    (All results shown here were generated from the same cDNA templates, the 
original RNA extracts showing similar amounts of ribosomal RNAs, Fig. 6.) 
Furthermore, incorporation of ectopically-expressed xRAP proteins is to be expected 
to be more efficient in mRNP complexes with a greater rate of turnover.  
 
 
4. Discussion 
4.1 xRAP is an integral component of poly(A)
+
RNP in early-stage oocytes 
    The protein composition of mRNP particles in early-stage oocytes was first defined 
by Darnbrough and Ford, 1981. Of the four most abundant proteins associated with 
poly(A)
+
RNA, two were characterized later as cold-shock domain Y-box proteins 
(YB2: Deschamps et al., 1992; Murray et al.,1992), a third as the DEAD-box RNA 
helicase Xp54/Dhh1 (Ladomery et al., 1997) and the last as the Scd6 family protein 
described here as xRAPB. We we define the main features of xRAPB and how they 
may contribute to differences in function from the other Scd6 protein also present in 
Xenopus oocytes, xRAPA. xRAPA is the homologue of RAP55 extesively studied in 
the cells of other vertebrates (Marnef et al., 2009).  
    Immunoblots with anti-Xp52/xRAPB show that the concentration of xRAPB 
decreases from early oogenesis to full-growth (Fig. 1C,E), a feature confirmed by 
immunostaining ovary sections (Fig. 1D), whereas the concentration of the translation 
repressor xRAPA increases during oogenesis (Tanaka et al., 2006). Cross-reacting 
antibodies clearly show this reciprocal expression pattern (Minshall et al., 2007).  
That xRAPB co-isolates with Xp54, YB2 and CPEB (Minshall et al., 2007) in 
association with polyadenylated mRNA (Fig. 1E) indicates that this mRNP may be 
capable of entering the translation pathway.  These observations can be compared 
with the timing of transcriptional activity which starts at maximum in early oocytes 
and decreases towards full growth and of the steady-state level of mRNA that exists 
from mid to late oogenesis, maintaining the pool of stored mRNA required for 
translation during oocyte maturation and early embryogenesis (Sommerville, 1990). 
Thus the availability of xRAPB matches the timing of translation of poly(A)
+
RNA to 
maximize oocyte growth, whereas the availability of xRAPA matches the 
accumulation of stored mRNA.  
 
4.2 Interaction of xRAPB with the RNA helicase Xp54  
    The ability of Xp54 and xRAPB to interact with each other: as in vitro-synthesized 
proteins (Fig. 2B); as native proteins (Fig. 2C; Minshall et al., 2009): as over-
expressed proteins (Fig. 3D), contrasts with a lack of comparable interaction of Xp54 
with xRAPA. Furthermore, co-expression of Xp54 with xRAPB leads to stabilization 
of xRAPB synthesis (Fig. 3C) and incorporation of both proteins into mRNP particles 
with a heterogeneous range of sizes (Fig. 3E), whereas co-expression xRAPA with 
Xp54 leads to the incorporation of xRAPA to the exclusion of Xp54, at least in fast-
sedimenting particles (Fig. 3F). All of these results confirm Xp54/xRAPB selectivity 
in the assembly of a specific class of mRNP particles during early- to mid-oogenesis.     
    During early oogenesis, YB2a/b are much more stable than Xp54 and xRAPB, 
which have similar turnover rates (Dixon and Ford, 1982). This reflects the inclusion 
of YB2a/b in mRNP particles that show continuing translation repression (longer term 
storage) and the inclusion of Xp54 and xRAPB in translation-ready mRNPs. Here we 
observed the reduction of YB2a/b in mRNP sedimentation classes that contain myc-
xRAPB (Fig. 5A) compared with the maintenance of YB2a/b in sedimentation classes 
in which native xRAPB is absent (Fig. 5C,E). Furthermore, the stability of the native 
Xp54/xRAPB/mRNA complex and removal of YB2a/b in high salt conditions (Fig. 
1F) is consistant with this functional grouping. However, activation of protein 
synthesis in early-stage oocytes may require dislocation, or conformational change 
(Minshall et al., 2009), of Xp54 from target mRNAs (see Section 4.3). The 
modification/stimulus required to release Xp54 from mRNP for translation activation 
is not known, although Xp54 phosphorylation (Sommerville, 1990: Weston and 
Sommerville 2006) and xRAPB methylation (Matsumoto et al., 2012) can be 
considered.  
 
4.3 Involvement of xRAPB in promoting translation  
    Evidence presented here, that over-expression of xRAPB can lead to an increase in 
the rate of amino acid incorporation (Fig. 4E,F), whereas knock-down suggests a 
decrease (Fig. 4C,D), contrasts with the predicted translation repression by Xp54 . 
However, ectopic expression of xRAPB tends to neutralize the repressor activity of 
ectopic Xp54 (Fig. 4F).   
The observation of an increase in the sedimentation rate of myc-xRAPB-containing 
RNP particles to post-80S fractions (Fig. 4A) is consistent with release of the 
bound/masked mRNA to enter into a translation initiation complex. Such ‘90S’ 
particles have been shown previously to contain, in addition to 80S ribosomes and 
poly(A)
+
mRNP particles, charged tRNAmet (Cummings and Sommerville, 1988). The 
transitions from repression to translation potentiation to translation may require 
sequential removal of masking and repressor proteins. Nevertheless, YB2 orthologues 
in mammalian cells (YB1/p50) and Chironomus cells (ctYB1) can remain associated 
with translating mRNAs, albeit with lower stoichiometry (Evdokimova and 
Ovchinikov, 1998; Soop et al., 2003). Thus, there is a precedent for core mRNP 
proteins being carried over into polysomes, as indicated with the detection of over-
expressed xRAPB in post-80S (Fig. 5A) and of native xRAPB in the polysomal region 
of glycerol gradients (Fig. 5C,E). What is significant is that the translation repressor 
Xp54 does not accompany xRAPB in these translocations. Whether xRAPB plays a 
direct role in translational release is not clear. However, it is interesting to note that 
the Scd6 paralogue expressed in trypanosomes does not form a complex with the 
p54/Dhh1 helicase (Cristodero et al., 2014), although this Scd6 protein, like xRAPA, 
acts as a translation repressor. In comparison, a fraction of xRAPB from early- to 
mid-stage oocytes, although apparently free of most of its accompanying Xp54 and 
YB2a/b, sediments in polysomal regions of glycerol gradients (Fig. 5A,E). The 
bimodal distribution formed is characteristic of free and translating mRNP, with all 
mRNP resolving to the free zone after treatment with EDTA (Fig. 5B). A similar 
situation has already been reported for ovarian tissue of Drosophila, where a 
proportion of the Scd6 protein Tral isolates with polysomes whereas the Dhh1 
orthologue Me31B isolates only in free mRNP particles (Liu et al., 2011). In Xenopus 
oocytes, intermediate gradient xRAPB-free fractions contain both Xp54 and YB2, 
indicating an alternative class of mRNP. That this is the case is confirmed by the 
identification, by slot-blot hybridization, of RNA extracted from the gradient fractions 
(Fig. 5C). Whereas early-translated mRNA (eg. encoding -tubulin) follows the 
distribution of xRAPB, stored mRNA (eg. encoding cyclin B1) is present in the 
intermediate zone. By late oogenesis and oocyte maturation, ectopically-expressed 
xRAPB is locates only in free (sub-80S) particles (Fig. 5F) 
 
4.4 Identification of catagories of mRNA that bind xRAPB 
     That the translated mRNAs are indeed associated with xRAPB and not xRAPA is 
shown by analysis of RT-PCR products of RNA co-immunoprecipitated with xRAPB 
and xRAPA (Fig. 6). All of the sequences derived from translating mRNAs were 
detected in xRAPB co-precipitates and to a much lesser extent in xRAPA co-
precipitates (Fig. 6, right column). Those tested included mRNAs encoding: structual 
proteins (oocyte-specific -tubulin and nuclear actin); translation components (EF1 
and ribosomal protein L14) and stored enzymes (maternal histone deacetylase, 
HDACm). In addition, however, a category of mRNAs that are not translated in 
oocytes was also immunoprecipitated along with xRAPB. These are mRNAs localized 
to the vegetal region in early-stage oocytes: encoding Xcat2/Nanos1 (Lai et al., 2011) 
and in mid-stage oocytes: encoding Vg1 (Kloc and Etkin, 2005). The co-precipitation 
of Vg1 mRNA with xRAPB is consistant with the previous demonstration that 
xRAPB, together with xRAPC (Fig. 1B), YB2 and Xp54 can be immunoprecipitated 
by antibodies recognizing Vg1-localizing proteins (Arthur et al., 2009). Here we have 
shown that early-localized particles containing Nanos1 mRNA appear also to contain 
xRAPB. Since Nanos mRNA is specifically translated in the next generation of 
precursor germ cells, perhaps xRAPB, if still bound, is required for its early 
activation. 
    Of the mRNAs not co-precipitated with xRAPB (Fig. 6, left column), co-
precipitation with xRAPA is also absent from those mRNAs not translated until egg 
formation (D7) or early embryogenesis (somatic YB1 and maternal linker histone 
H1M). Although the mRNAs to be translated during oocyte maturation (cyclinB1 and 
c-mos) do appear to have bound xRAPA, the mRNAs themselves appear to be 
unstable. This may well be due to the over-expression of xRAPA, known to be a 
component involved with Xp54 in the RNA degradation pathway. This highlights a 
potential limitation of the use of epitope-tagged proteins as a target for 
immunoprecipitation: although they present optimum antigenicity, their over-
expression may lead to metabolic side-effects. 
 
4. 5 mRNA storage versus translation and turnover 
    Induction of mRNA degradation by over-expressed RAP55/RAPA has been well 
documented for a wide range of organisms (Marnef et al., 2009) and in vertebrates 
appears to be essential for the formation of P-bodies.  Xenopus xRAP55 (xRAPA) has 
been shown to be present in non-defined cytoplasmic foci in oocytes and to locate to 
P-bodies when expressed in mammalian cells (Tanaka et al., 2006). Furthermore, 
tethering of xRAP55 to a reporter mRNA expressed in late-stage oocytes caused a 
decrease in the levels of the reporter protein. However, early growth of mouse oocytes 
is accompanied by the loss of P-bodies and translocation of mRNP complexes 
(lacking decapping enzymes) to sub-cortical regions (Flemr et al., 2010). Also, the 
involvement of the Scd6 protein involved in mRNP storage granule formation in 
trypanosomes does not correlate with translation repression of granule-recruited 
mRNA (Kruger et al., 2013). Translationally silent mRNAs in the gametocytes of 
Plasmodium are contained in storage granules defined by the presence of the Dhh1 
and Scd6 orthologues, DOZ1 and CITH, but the absence of RNA degradation factors 
(Mair et al., 2010). Thus germ cells, from single-celled organisms to those of 
multicelled organisms present a special case in the use of Dhh1 and Scd6 for mRNA 
storage and distribution rather than degradation.  
    The major feature of Scd6 proteins in oogenic/embryonic systems lies in their 
efficient handling of mRNA through the developmental programme. In Xenopus 
oocytes, at least, this is managed through the involvement if different Scd6 proteins; 
xRAPA and xRAPB and possibly others. As argued here, xRAPB is responsible for 
the selective distribution and translation, from the total pool, of those mRNAs 
required for cell reorganization and growth, whereas xRAPA is required for 
translation repression and storage of those mRNAs required for late oogenesis and 
meiosis.  Since RAPB paralogues are expressed in a wide range of organisms, 
including mouse and human, their further functions should be well worth 
investigating. 
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Figure legends 
Fig. 1. Identification and expression of xRAPB (A) Immunoblot of poly(A)
+
 fractions 
from oocytes of Xenopus laevis and Pleurodeles waltl  reacted with guinea pig anti-
RAP55 and rabbit anti-RNP2/Xp52. (B) Alternative designations of the two Xenopus 
Scd6 proteins described here (right panel) and percentage identities of the three 
proteins described to date. (C) Comparison of expression through oocyte stages of 
Xp52 and the RT-PCR products of the mRNA encoding Xp52. (D) Immunostaining 
of ovary section with anti-RNP2 showing reaction with stages I – IV. Perimeters of 
the stage III and IV oocytes are indicated by white outlines. Bar indicates 200 m. (E) 
Immunoblot of extracts from previtellogenic (stage I) oocytes and mature oocytes, 
unbound (UB) and bound (B) by oligo(dT) cellulose. Lysates were obtained in the 
presence of 2mM Mg2Cl or 5 mM EDTA. The transfer was reacted serially with anti-
RNP2 (recognizing xRAPB); anti-Xp54; anti-RNP1 (YB2) ; anti-CPEB; anti-ERK2 
and anti-phosphorylated MAPkinase (pMAPK). (F) Immunoblot of density gradient 
fractions of poly(A)
+
 RNP reacted with anti-RNP1 (YB2) and anti-RNP2 (xRAPB). 
Slot blots of RNA extracted from the same fractions (lower panels) were reacted with 
32
P-labelled anti-sense probes recognizing the mRNAs of nucleolin and histone 
deacetylase (HDAC). 
 
Fig. 2. Interactions of xRAPB and xRAPA with Xp54. (A) Autoradiographs of SDS-
PAGE gels showing in vitro interactions of 
35
S-labelled recombinant proteins. The 
proteins were synthesized and labelled by coupled transcription/translation using 
cloned cDNAs in a reticulocyte lysate system (left panel).  Single and mixed products 
were incubated and subjected to u.v.-cross-linking (UV) and/or digestion with 
ribonuclease A (RNase; 1 mg/ml). Large complexes are trapped at the top of the gels 
(arrows). Interactions resulting from mixtures of xRAPA and Xp54 (middle panel) 
and xRAPB and Xp54 (right panel) are shown. Percentage depletion of each 
component from its monomer band due to uv.-treatment, or partial recovery due to 
ribonuclease treatment, are shown beneath each track. (B) Immunoprecipitations of 
35
S-labelled xRAPB/Xp54 and xRAPA/Xp54 mixes with immobilized anti-Xp54 and 
anti-RNP2. Bound (B) and unbound (UB) fractions. (C) Immunostained transfers 
from SDS-PAGE gels of oocyte poly(A)
+
 RNP, untreated and u.v.-cross-linked (UV) 
with subsequent digestion with ribonuclease A. Putative, cross-linked Xp54/xRAPB 
heterodimers (~110 kDa) are recognized by anti-Xp54 and anti-RNP2. The two other 
major mRNP proteins, FRGY2a/b, are not detected in cross-linked complexes with 
this same mobility. 
 
Fig. 3. Complementation of xRAPB and Xp54 in the formation of mRNP particles.  
(A) Recombinant proteins produced from expression vectors used in this study. (B) 
Time course of translation in vivo from RNA transcripts encoding myc-tagged 
xRAPB, with and without co-translation of Xp54. The RNA was injected into the 
cytoplasm of stage III oocytes. (C) Immunoprecipitation from lysates of oocytes co-
expressing xRAPB and Xp54. Expression vectors encoding epitope-tagged proteins 
(Fig. 3A) were injected into the nuclei of stage IV oocytes, which were incubated for 
36 h before extraction. Proteins were unbound (UB) or bound (B) to immobilized 
anti-myc, anti-T7, anti-RNP2 or anti-Xp54 and separated by SDS-PAGE. The transfer 
was serially reacted with anti-RNP2 and anti-Xp54. (D and E) Sedimentation 
analysis of mRNP particles formed during the co-expression of xRAPB and Xp54 and 
xRAPA and Xp54. Glycerol gradient fractions were separated by SDS-PAGE and 
immunoblotted using first anti-myc, then anti-T7. Equal volumes of extracts were pre-
treated with ribonuclease A (+RNase) prior to sedimentation. Ribosomal monomers 
sediment to the bottom of the centrifuge tubes, the pellet also containing larger 
complexes (80S+). 
 
Fig. 4. Effects of knock-down and over-expression of xRAPA and xRAPB on 
translation rate and mRNP size distribution. (A) Effect of antisense morpholinos 
(a/sMOs) recognizing the translation start sites of endogenous xRAPB and Xp54 at 24 
and 48h after cytoplasmic injection into stage III oocytes. Control is a random 
sequence MO. (B) Effect of a/s MOs on co-expressed myc-xRAPB and T7-Xp54. 
Vector injections as for Fig. 4B with MO injections after 12 h. (C) Effect of a/sMOs 
recognizing xRAPA (A), xRAPB (B), Xp54 (P) on the rate of amino acid 
incorporation. Oocytes were injected with MOs were incubated for 12 h before 
addition of [
35
S]-methionine to the medium. Oocytes from each set were recovered at 
hourly intervals and processed to obtain percentage of radioactivity incorporated into 
protein. Data from three separate experiments were used to obtain means and standard 
deviations. Autoradiographs of SDS-PAGE separated proteins were also obtained 
(panel on right). (D) As for (C) but with nuclear injection of expression vectors 
replacing MO injection. Bands attributed to the ectopically-expressed proteins were 
subtracted from measurement of intensity totals (white spots). (E) Sedimentation 
analysis of extracts from stage IV oocytes, expressing either myc-xRAPA (upper 
panels) or myc-xRAPB (lower panels). Gradient fractions separated by SDS-PAGE 
and immunoblotted with anti-myc, anti-Xp54 and anti-RNP1 (YB2). Fastest 
sedimenting mRNP fractions containing myc-xRAPA are boxed in blue, and those 
containing myc-xRAPB are boxed in red. (F) As (E) but with 5mM EDTA replacing 
2mM Mg
2+
. Peak sedimentation of ribosomal monosomes (80S) and sub-units (60S 
and 40S) are indicated as rate markers. 
 
Fig. 5. Properties of native xRAPB relating to early translation. (A)  Sedimentation 
analysis of extract from stage III oocytes treated with 50 g/ml cycloheximide 
(CHX). Gradient fractions were separated by SDS-PAGE and immunoblotted with 
anti-RNP2 (xRAPB), anti-Xp54 and anti-RNP1 (YB2). Fractions of mRNP lacking 
xRAPB are boxed in red. RNA extracted from aliquots of each of the gradient 
fractions was applied to a membrane by slot-blotting, the blot being subsequently 
hybridized with radio-labelled probes, antisense to mRNA encoding oocyte-specific 
-tubulin and cyclin B1. Autoradiographs are shown (bottom panels). (B) As (A) but 
with 5mM EDTA replacing cycloheximide. (C) Hybridizations were also performed 
using transfers after RNA gel electrophoresis, the samples being obtained from total 
RNA (T), its polysomal pellet (P) and its non-polysomal supernatant (S). Probes used 
in autoradiographs shown are anti-sense to mRNA encoding ribosomal protein S27 
(top panel) and FRGY1 (bottom panel). (D) Analysis of mRNAs immunoprecipitated 
(IP) by anti-myc from extracts from oocytes expressing xRAPA or xRAPB. RNA 
extracted from unbound (UB) and bound (B) fractions was used as templates for RT-
PCR, amplification using gene-specific primers for X. laevis oocyte -tubulin, histone 
deacetylase HDACm, cyclin B1 and maternal linker histone H1M. Products are 
separated on 1.5% agarose gels. Ribosomal RNAs (28S+18S and 5S) isolated from 
the same IP fractions are also shown (bottom panels). 
 
 
 
 






